BACKGROUND: The purpose of the study was to investigate and compare iloprost and levosimendan on spinal cord ischemia in an experimental model. MATERIALS AND METHODS: The study was done in two stages. For the 4-hour short survival study, 50 New Zealand white rabbits were randomly allocated into five groups. Spinal cord ischemia was induced by clamping the aorta just below the left renal artery and just proximal to the aortic bifurcation with bulldog artery clamps. The aortic clamps were removed after 40 min and restoration of blood flow was verified visually. The groups were analyzed at 1 and 4 h after reperfusion. For the 48-hour survival study, two different groups (iloprost plus levosimendan, n = 10; saline-treated controls, n = 10) were analyzed at 24 and 48 h after reperfusion. RESULTS: The neurologic status of the animals in the treatment and sham groups was better than that in the control group both at 1 and 4 h after reperfusion. Viability index values in the levosimendan, iloprost and iloprost plus levosimendan groups were statistically higher than in the control group indicating less or no neuronal damage. DISCUSSION: The results suggest that levosimendan, as well as iloprost, may reduce ischemic damage in transient spinal ischemia and provide better neurologic outcome. Copyright 2008 S. Karger AG, Basel.
BACKGROUND: The purpose of the study was to investigate and compare iloprost and levosimendan on spinal cord ischemia in an experimental model. MATERIALS AND METHODS: The study was done in two stages. For the 4-hour short survival study, 50 New Zealand white rabbits were randomly allocated into five groups. Spinal cord ischemia was induced by clamping the aorta just below the left renal artery and just proximal to the aortic bifurcation with bulldog artery clamps. The aortic clamps were removed after 40 min and restoration of blood flow was verified visually. The groups were analyzed at 1 and 4 h after reperfusion. For the 48-hour survival study, two different groups (iloprost plus levosimendan, n = 10; saline-treated controls, n = 10) were analyzed at 24 and 48 h after reperfusion. RESULTS: The neurologic status of the animals in the treatment and sham groups was better than that in the control group both at 1 and 4 h after reperfusion. Viability index values in the levosimendan, iloprost and iloprost plus levosimendan groups were statistically higher than in the control group indicating less or no neuronal damage. DISCUSSION: The results suggest that levosimendan, as well as iloprost, may reduce ischemic damage in transient spinal ischemia and provide better neurologic outcome. Copyright 2008 S. Karger AG, Basel.
Authors: Anna B Roehl; Marc Hein; Philipp D Loetscher; Jan Rossaint; Joachim Weis; Rolf Rossaint; Mark Coburn Journal: BMC Neurol Date: 2010-10-21 Impact factor: 2.474
Authors: Koji Hirano; Klaus Wagner; Peter Mark; Erik Pittermann; Ralf Gäbel; Dario Furlani; Wenzhong Li; Brigitte Vollmar; Tomomi Yamada; Gustav Steinhoff; Nan Ma Journal: J Cell Mol Med Date: 2012-08 Impact factor: 5.310
Authors: Andreas García-Bardon; Jens Kamuf; Alexander Ziebart; Tanghua Liu; Nadia Krebs; Bastian Dünges; Robert F Kelm; Svenja Morsbach; Kristin Mohr; Axel Heimann; Erik K Hartmann; Serge C Thal Journal: Sci Rep Date: 2021-07-09 Impact factor: 4.379
Authors: Anna B Roehl; Norbert Zoremba; Markus Kipp; Johannes Schiefer; Andreas Goetzenich; Christian Bleilevens; Nikolaus Kuehn-Velten; Rene Tolba; Rolf Rossaint; Marc Hein Journal: BMC Neurol Date: 2012-08-24 Impact factor: 2.474